DRC Gets First Mpox Vaccine Shipment & Issues EUA Ahead Of WHO Listing

The Democratic Republic of Congo, the country worst hit by the mpox crisis, has now received the first batch of vaccines for the disease. Meanwhile, the World Health Organization is expected to complete its review for emergency use listing of mpox vaccines soon.

The first mpox vaccines have arrived in the Democratic Republic of Congo • Source: Shutterstock

A large portion of the 215,000 or so doses of the mpox vaccine Jynneos that the EU and the product’s developer Bavarian Nordic are donating as an immediate response to the disease’s outbreak in Africa has arrived in the Democratic Republic of Congo.

Key Takeaways
  • A shipment of 99,100 doses of Bavarian Nordic’s mpox vaccine, Jynneos, has arrived in the Democratic Republic of Congo and another 100,900 doses are due to arrive on 7 September.

The first shipment of 99,100 doses of Jynneos (smallpox and monkeypox vaccine (live modified vaccinia virus Ankara)) was delivered in...

Welcome to Pink Sheet

Create an account to read this article

More from Vaccines

Senate Panel Approves US CDC Director Candidate Monarez With Measles Outbreak Growing

 
• By 

The Senate Health, Education, Labor and Pensions Committee voted to advance Monarez's nomination to lead the CDC as the agency announced the largest US measles outbreak in 22 years.

US FDA Advisory Committee Supports Vaccine Safety, Scrutinizes AE Reporting Quality

 
• By 

The Pediatric Advisory Committee supported routine safety monitoring for three vaccines and 21 drugs, but the panel’s consumer representative said adverse event reporting needs improvement and FDA literature reviews should include lawsuits as well as social media.

US FDA Pediatric Adcomm To Examine HPV, Flu, Dengue Vaccines: No News Is Good News?

 
• By 

Pediatric Advisory Committee will weigh the FDA's recommendation that routine safety monitoring continue for Merck & Co's Gardasil and Sanofi's Fluzone and Dengvaxia despite a political climate that has been unkind to vaccines.

England’s NHS Plan Eyes Cancer Vaccine Boost, Single Formulary & ‘Pay For Impact’ Drug Deal

 

The creation of a single national formulary for medicines prescribing that could impact industry is among the action points in the UK government’s new 10-year health plan for the National Health Service in England.

More from Middle East & Africa

New Measures Can Cut Israel’s Drug Approval Time To Just 70 Days

 

Israel has introduced a new framework to expedite the marketing approval of medicines, make the country a more attractive destination for drug registration and help reduce drug prices through market competition.

Landmark Pilot Paves Way for Faster Drug Approvals In Africa

 

In a historic move for Africa, five products have been backed for approval via a pilot that tested a continental listing process.

Africa Partners With PIC/S To Elevate GMP Standards And Accelerate AMA’s Rollout

 

Efforts have stepped up to enhance Africa’s capacity to meet international good manufacturing practice standards, empower regulators across the continent, and drive sustainable growth in the pharmaceutical sector.